Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

Lilian Plotkin, Robert S. Weinstein, A. Michael Parfitt, Paula K. Roberson, Stavros C. Manolagas, Teresita Bellido

Research output: Contribution to journalArticle

704 Citations (Scopus)

Abstract

Glucocorticoid-induced osteoporosis may be due, in part, to increased apoptosis of osteocytes and osteoblasts, and bisphosphonates (BPs) are effective in the management of this condition. We have tested the hypothesis that BPs suppress apoptosis in these cell types. Etidronate, alendronate, pamidronate, olpadronate, or amino-olpadronate (IG9402, a bisphosphonate that lacks antiresorptive activity) at 109 to 106 M prevented apoptosis of murine osteocytic MLO-Y4 cells, whether it was induced by etoposide, TNF-α, or the synthetic glucocorticoid dexamethasone. BPs also inhibited apoptosis of primary murine osteoblastic cells isolated from calvaria. Similar antiapoptotic effects on MLO-Y4 and osteoblastic cells were seen with nanomolar concentrations of the peptide hormone calcitonin. The antiapoptotic effect of BPs and calcitonin was associated with a rapid increase in the phosphorylated fraction of extracellular signal regulated kinases (ERKs) and was blocked by specific inhibitors of ERK activation. Consistent with these in vitro results, alendronate abolished the increased prevalence of apoptosis in vertebral cancellous bone osteocytes and osteoblasts that follows prednisolone administration to mice. These results suggest that the therapeutic efficacy of BPs or calcitonin in diseases such as glucocorticoid- induced osteoporosis may be due, in part, to their ability to prevent osteocyte and osteoblast apoptosis.

Original languageEnglish (US)
Pages (from-to)1363-1374
Number of pages12
JournalJournal of Clinical Investigation
Volume104
Issue number10
StatePublished - Nov 1999
Externally publishedYes

Fingerprint

Osteocytes
Diphosphonates
Calcitonin
Osteoblasts
Apoptosis
Glucocorticoids
Alendronate
pamidronate
Extracellular Signal-Regulated MAP Kinases
Osteoporosis
Etidronic Acid
Peptide Hormones
Etoposide
Prednisolone
Skull
Dexamethasone

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Plotkin, L., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999). Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. Journal of Clinical Investigation, 104(10), 1363-1374.

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. / Plotkin, Lilian; Weinstein, Robert S.; Parfitt, A. Michael; Roberson, Paula K.; Manolagas, Stavros C.; Bellido, Teresita.

In: Journal of Clinical Investigation, Vol. 104, No. 10, 11.1999, p. 1363-1374.

Research output: Contribution to journalArticle

Plotkin, L, Weinstein, RS, Parfitt, AM, Roberson, PK, Manolagas, SC & Bellido, T 1999, 'Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin', Journal of Clinical Investigation, vol. 104, no. 10, pp. 1363-1374.
Plotkin, Lilian ; Weinstein, Robert S. ; Parfitt, A. Michael ; Roberson, Paula K. ; Manolagas, Stavros C. ; Bellido, Teresita. / Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. In: Journal of Clinical Investigation. 1999 ; Vol. 104, No. 10. pp. 1363-1374.
@article{9be58ad2a91d4705aa5dc845377e3108,
title = "Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin",
abstract = "Glucocorticoid-induced osteoporosis may be due, in part, to increased apoptosis of osteocytes and osteoblasts, and bisphosphonates (BPs) are effective in the management of this condition. We have tested the hypothesis that BPs suppress apoptosis in these cell types. Etidronate, alendronate, pamidronate, olpadronate, or amino-olpadronate (IG9402, a bisphosphonate that lacks antiresorptive activity) at 109 to 106 M prevented apoptosis of murine osteocytic MLO-Y4 cells, whether it was induced by etoposide, TNF-α, or the synthetic glucocorticoid dexamethasone. BPs also inhibited apoptosis of primary murine osteoblastic cells isolated from calvaria. Similar antiapoptotic effects on MLO-Y4 and osteoblastic cells were seen with nanomolar concentrations of the peptide hormone calcitonin. The antiapoptotic effect of BPs and calcitonin was associated with a rapid increase in the phosphorylated fraction of extracellular signal regulated kinases (ERKs) and was blocked by specific inhibitors of ERK activation. Consistent with these in vitro results, alendronate abolished the increased prevalence of apoptosis in vertebral cancellous bone osteocytes and osteoblasts that follows prednisolone administration to mice. These results suggest that the therapeutic efficacy of BPs or calcitonin in diseases such as glucocorticoid- induced osteoporosis may be due, in part, to their ability to prevent osteocyte and osteoblast apoptosis.",
author = "Lilian Plotkin and Weinstein, {Robert S.} and Parfitt, {A. Michael} and Roberson, {Paula K.} and Manolagas, {Stavros C.} and Teresita Bellido",
year = "1999",
month = "11",
language = "English (US)",
volume = "104",
pages = "1363--1374",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "10",

}

TY - JOUR

T1 - Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

AU - Plotkin, Lilian

AU - Weinstein, Robert S.

AU - Parfitt, A. Michael

AU - Roberson, Paula K.

AU - Manolagas, Stavros C.

AU - Bellido, Teresita

PY - 1999/11

Y1 - 1999/11

N2 - Glucocorticoid-induced osteoporosis may be due, in part, to increased apoptosis of osteocytes and osteoblasts, and bisphosphonates (BPs) are effective in the management of this condition. We have tested the hypothesis that BPs suppress apoptosis in these cell types. Etidronate, alendronate, pamidronate, olpadronate, or amino-olpadronate (IG9402, a bisphosphonate that lacks antiresorptive activity) at 109 to 106 M prevented apoptosis of murine osteocytic MLO-Y4 cells, whether it was induced by etoposide, TNF-α, or the synthetic glucocorticoid dexamethasone. BPs also inhibited apoptosis of primary murine osteoblastic cells isolated from calvaria. Similar antiapoptotic effects on MLO-Y4 and osteoblastic cells were seen with nanomolar concentrations of the peptide hormone calcitonin. The antiapoptotic effect of BPs and calcitonin was associated with a rapid increase in the phosphorylated fraction of extracellular signal regulated kinases (ERKs) and was blocked by specific inhibitors of ERK activation. Consistent with these in vitro results, alendronate abolished the increased prevalence of apoptosis in vertebral cancellous bone osteocytes and osteoblasts that follows prednisolone administration to mice. These results suggest that the therapeutic efficacy of BPs or calcitonin in diseases such as glucocorticoid- induced osteoporosis may be due, in part, to their ability to prevent osteocyte and osteoblast apoptosis.

AB - Glucocorticoid-induced osteoporosis may be due, in part, to increased apoptosis of osteocytes and osteoblasts, and bisphosphonates (BPs) are effective in the management of this condition. We have tested the hypothesis that BPs suppress apoptosis in these cell types. Etidronate, alendronate, pamidronate, olpadronate, or amino-olpadronate (IG9402, a bisphosphonate that lacks antiresorptive activity) at 109 to 106 M prevented apoptosis of murine osteocytic MLO-Y4 cells, whether it was induced by etoposide, TNF-α, or the synthetic glucocorticoid dexamethasone. BPs also inhibited apoptosis of primary murine osteoblastic cells isolated from calvaria. Similar antiapoptotic effects on MLO-Y4 and osteoblastic cells were seen with nanomolar concentrations of the peptide hormone calcitonin. The antiapoptotic effect of BPs and calcitonin was associated with a rapid increase in the phosphorylated fraction of extracellular signal regulated kinases (ERKs) and was blocked by specific inhibitors of ERK activation. Consistent with these in vitro results, alendronate abolished the increased prevalence of apoptosis in vertebral cancellous bone osteocytes and osteoblasts that follows prednisolone administration to mice. These results suggest that the therapeutic efficacy of BPs or calcitonin in diseases such as glucocorticoid- induced osteoporosis may be due, in part, to their ability to prevent osteocyte and osteoblast apoptosis.

UR - http://www.scopus.com/inward/record.url?scp=0032722149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032722149&partnerID=8YFLogxK

M3 - Article

C2 - 10562298

AN - SCOPUS:0032722149

VL - 104

SP - 1363

EP - 1374

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 10

ER -